Prof Philippos C. Patsalis
Prof Philippos C. Patsalis was born in Athienou, Cyprus in 1962. Prof. Patsalis received his BSc degree from the Aristotelian University of Salonica, Greece and his MA, MPh and PhD degrees from the City University of New York, USA. He underwent specialization training in Human Genetics at Memorial Sloan-Kettering Center and the Cornell Medical Center, USA. His post-doctoral training was done at the Institute Pasteur, France and the New York University, Memorial-Sloan Kettering Cancer Center and Columbia University, in New York, USA. He also received professional certification and licensing to practice as a Laboratory Director in the specialties of Cytogenetics and Molecular Genetics from the New York Department of Health, USA; American Board Certification as High Complexity Laboratory Director from the American Board of Bioanalysis, USA; and Accreditation as Laboratory Director in Cytogenetics and Molecular Genetics from the College of American Pathologists, USA. As of 2007, Prof. Patsalis is the Chief Executive Medical Director of The Cyprus Institute of Neurology and Genetics and as of 2011 Professor and Chief Executive Director of the Cyprus School of Molecular Medicine. He is also an Honorary Professor of the St. George’s University of London/Medical School at the University of Nicosia, Adjunct Professor at the University of Cyprus/Department of Biology and Visiting Professor at the University of Ioannina/Medical School. He is the Founder of the Cyprus School of Molecular Medicine, the bio-technology spin-off company NIPD Genetics, and the Department of Cytogenetics and Genomics as well as the Translational Genetic Team at the Cyprus Institute of Neurology and Genetics. Prof. Patsalis has several national and international affiliations such as President of the National Committee of Research, Innovation and Technological Development, President of the Cyprus Council of Directors of Research Institutes, President of the Cyprus Society of Human Genetics, Board Member of the European Cytogenetic Association, Board Member of the European Society of Human Genetics, etc. He is the Cyprus National Representative in several European organizations, such as the European Cytogeneticists Association, the European Union COST Action, EuroGenTest European Forum, etc. He is a scientist with an international reputation in the field of Genetics. He was invited to provide lectures in more than 100 universities and conferences around the world. During the last several years he has obtained many competitive research grants, including grants from the 5th, 6th, and 7th European Framework Programmes and the most prestigious grant in the European Union known as the ERC Advanced Grant, which is given to very few senior scientists in Europe and is based purely on excellence. He has been appointed to the Editorial Board of international scientific journals in the field of Cytogenetics and Genomics, such as BMC Medical Genomics, Molecular Cytogenetics, Applied and Translational Genomics, etc. He has contributed chapters in seven books and has published more than 100 peer review papers in scientific journals including Nature Medicine, Lancet, Human Molecular Genetics, American Journal Human Genetics, etc. Prof. Patsalis is the principal investigator and group leader of the research team which invented and patented the Non-Invasive Prenatal Diagnosis for Down Syndrome, recently published in Nature Medicine. He has received several national and international awards in recent years, including the National Research Award 2008, the National Innovation Award 2009, the Most Notable Scientific and Social Contribution Award University of Nicosia 2011, the US State Alumni Award-State Department US 2011, Man of the Year 2011 and the Silver Medal of the Parliament, which is the highest honorary distinction of the Parliament of the Republic of Cyprus, in 2012. In October 2013, the President of the Republic of Cyprus awarded him with a national award, in recognition of his outstanding contribution to scientific research and being awarded the ERC Advanced Program of Excellence from the European Research Council.